Plasma level of N-terminal containing tau fragments (NTA-tau) increases across the AD continuum, especially during mid-to-late AD stages, and it is closely associated with in vivo tau tangle deposition in AD and its downstream effects [565]. The gene discussed is MAPT; the disease is Alzheimer disease.